Large animal studies are an important step toward clinical translation of novel therapeutic approaches. We aimed to establish an ischemic heart failure (HF) model with a larger myocardial infarction (MI) relative to previous studies, and characterize the functional and structural features of this model. An MI was induced by occluding the proximal left anterior descending artery (LAD; n ϭ 15) or the proximal left circumflex artery (LCx; n ϭ 6) in Yorkshire pigs. Three pigs with sham procedures were also included. All pigs underwent hemodynamic and echocardiographic assessments before MI, at 1 mo, and 3 mo after MI. Analyses of left ventricular (LV) myocardial mechanics by means of strains and torsion were performed using speckle-tracking echocardiography and compared between the groups. The proximal LAD MI approach induced larger infarct sizes (14.2 Ϯ 3.2% vs. 10.6 Ϯ 1.9%, P ϭ 0.03), depressed systolic function (LV ejection fraction; 39.8 Ϯ 7.5% vs. 54.1 Ϯ 4.6%, P Ͻ 0.001), and more LV remodeling (end-systolic volume index; 82 Ϯ 25 ml/m 2 vs. 51 Ϯ 18 ml/m 2 , P ϭ 0.02, LAD vs. LCx, respectively) compared with the LCx MI approach without compromising the survival rate. At the papillary muscle level, echocardiographic strain analysis revealed no differences in radial and circumferential strain between LAD and LCx MIs. However, in contrast with the LCx MI, the LAD MI resulted in significantly decreased longitudinal strain. The proximal LAD MI model induces more LV remodeling and depressed LV function relative to the LCx MI model. Location of MI significantly impacts the severity of HF, thus careful consideration is required when choosing an MI model for preclinical HF studies.anterior; posterior; remodeling; torsion; sphericity THE STATISTICAL REPORT FROM the American Heart Association revealed a decline in mortality attributable to cardiovascular diseases by 30.6% in the last decade. However, one out of three patients still die from cardiovascular diseases in the US and the mortality in heart failure (HF) patients remains high (31). Significant progresses in treatment devices as well as modern pharmacotherapy have improved prognoses, while efforts on greater improvements continue. Several novel treatments for HF including gene therapy and cell therapy, and novel pharmaceuticals show promising results in small animal experimental studies. However, structural and physiological differences between human and small animals (27) continue to limit their clinically relevant predictive value for translating to humans. Hence, the need for large animal studies is still required to validate the efficacy and safety of these novel treatments in more clinically relevant models of HF.There are several large animal models of HF using diverse species. Pigs, dogs, and sheep are frequently used animals in translational experimental studies of cardiovascular diseases (18). Among them, the pig is most common due to similar coronary anatomies to humans, lack of inherent coronary collaterals, and ease of handling (14). HF can be induced b...